Steady-state Bioequivalence Study of Aripiprazole for Injection in Patients With Schizophrenia.

by | Apr 23, 2026 | Clinical Trials | 0 comments

​ Conditions: Schizophrenia

Interventions: Drug: Aripiprazole for Injection; Drug: Aripiprazole for Injection

Sponsors: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.

Not yet recruiting Conditions: Schizophrenia
Interventions: Drug: Aripiprazole for Injection; Drug: Aripiprazole for Injection
Sponsors: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *